Specifically, androgen receptor (AR) is known to be expressed in80–90% of ER+ breast cancers (9) and there is a recent evidence showing that in the absence of ER, AR cansubstitute for ER and initiate cell division in an ER-independent, but nuclearreceptor-dependent manner (10, 11). Here, ESR1 is linked to breast carcinoma.